Keyphrases
Antiproliferative Activity
100%
Antitumor
12%
Cdc2
37%
Cdc25
12%
Cell Cycle Progression
12%
Cell Growth
25%
Chemoresistant
100%
Cip1
12%
Cisplatin
25%
Cisplatin Resistance
12%
Cisplatin-induced
25%
Cyclin B1
25%
Elemene
100%
G2 Checkpoint
12%
G2-M Arrest
25%
GADD45A
12%
Growth Inhibition
12%
Growth Suppression
12%
Human Ovarian Cancer Cell
12%
Human Ovary
12%
Induced Growth
25%
Inhibitory Effect
12%
Life Cycle Analysis
12%
M Phase
100%
Marginal Effects
12%
Normal Ovary
12%
Ovarian Cancer
12%
Ovarian Cancer Cells
12%
Ovarian Carcinoma Cells
100%
Ovarian Cells
25%
P21Cip1
12%
P27Kip1
12%
Phosphorylation
12%
Plant Drugs
12%
Resistant Cells
12%
Synergistic Effect
12%
Biochemistry, Genetics and Molecular Biology
Antiproliferative Activity
100%
Cancer Cell
40%
Cell Cycle
100%
Cell Cycle M Phase
100%
Cell Cycle Progression
20%
Cell Growth
40%
Cell-Cycle Analysis
20%
Cisplatin
100%
Cyclin B1
40%
G2 Phase Cell Cycle Checkpoint
20%
Gadd45
20%
Growth Inhibition
40%
Mitosis
100%
P53
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cisplatin
100%
Cyclin B1
40%
Ovary Cancer
60%
Ovary Carcinoma
100%
Protein P53
20%